In a first in the Indian Super League, a footballer has tested positive for use of banned substance. The league has a zero-tolerance policy for doping and Delhi Dynamos player Rana Gharami has been charged with a violation of the NADA Anti-Doping Rules and he can be barred from playing for four years.
Tested on January 31, Prednisone and Prednisolone metabolities were found in Gharami's system for which the defender didn't have a therapeutic use exemption.
As per the report, accessed by IANS, he has been charged with presence of Prednisone, 20-B-OH-Prednisolone, Glucocorticosteroids in his sample.
If NADA establishes that the rule violation was intentional, the player will be ineligible for four years since it is his first offence.
If NADA fails to do so, the ineligible period will start at two years, subject to further potential reductions in accordance to article 10.4, 10.5 or 10.6 of the anti-doping rules.
Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders.
Athletes sometimes misuse it as it helps in increased energy and improves performance.
The player will not be provisionally suspended pending the resolution of the case and can continue to participate in competitions or events.
However, once the results obtained will be disqualified from the date of his adverse analytical finding through the commencement of any provisional suspension or period of ineligibility.
The player now either get his 'B' Sample tested or can accept the charge and face the consequences. He can also accept the charge but not agree to the consequences and request for a hearing.
The player has been given a week to reply to the notice and make his decision known.
A copy of the notice has also been sent to the AIFF general secretary Kushal Das, FIFA and World Anti-Doping Agency.
(Baidurjo Bhose can be contacted at baidurjo.b@ians.in)
--IANS
bbh/in
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
